[EEG changes under sodium diethyldithiocarbamate therapy in 2 cases of Wilson's disease].
D000328:Adult; D002614:Chelating Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003072:Cognition Disorders / Q000139:chemically induced; D003300:Copper / Q000097:blood / Q000652:urine; D004569:Electroencephalography; D005260:Female; D006527:Hepatolenticular Degeneration / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D010396:Penicillamine / Q000009:adverse effects; D013859:Thiocarbamates / Q000009:adverse effects* / Q000627:therapeutic use
D002614:Chelating Agents; D013859:Thiocarbamates; D003300:Copper; D010396:Penicillamine
EEG-Veränderungen unter Natriumdiäthyldithiocarbamat-Behandlung bei zwei Fällen von Morbus Wilson.